Response

Affiliations

¹ Affiliations of authors: Institute of Cancer and Genetics (CGS, HW, RH, SI, JPC) and Institute of Psychological Medicine and Clinical Neurosciences (VM), School of Medicine, Cardiff University, Cardiff, UK; Gray Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK (TSM); MRC Clinical Trials Unit, London, UK (RK); Wellcome Trust Brenner Building, St James' University Hospital, University of Leeds, Leeds, UK (SR, PQ, MS); Institute of Human Genetics, University Hospital Bonn, Bonn, Germany (VS, PP); Leiden University Medical Center, Department of Clinical Genetics, Leiden, The Netherlands (FJH, JW).
² Affiliations of authors: Institute of Cancer and Genetics (CGS, HW, RH, SI, JPC) and Institute of Psychological Medicine and Clinical Neurosciences (VM), School of Medicine, Cardiff University, Cardiff, UK; Gray Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK (TSM); MRC Clinical Trials Unit, London, UK (RK); Wellcome Trust Brenner Building, St James' University Hospital, University of Leeds, Leeds, UK (SR, PQ, MS); Institute of Human Genetics, University Hospital Bonn, Bonn, Germany (VS, PP); Leiden University Medical Center, Department of Clinical Genetics, Leiden, The Netherlands (FJH, JW). cheadlejp@cardiff.ac.uk.

Comment

Christopher G Smith et al. J Natl Cancer Inst. 2014.

. 2014 Apr 26;106(5):dju087.

doi: 10.1093/jnci/dju087.

¹ Affiliations of authors: Institute of Cancer and Genetics (CGS, HW, RH, SI, JPC) and Institute of Psychological Medicine and Clinical Neurosciences (VM), School of Medicine, Cardiff University, Cardiff, UK; Gray Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK (TSM); MRC Clinical Trials Unit, London, UK (RK); Wellcome Trust Brenner Building, St James' University Hospital, University of Leeds, Leeds, UK (SR, PQ, MS); Institute of Human Genetics, University Hospital Bonn, Bonn, Germany (VS, PP); Leiden University Medical Center, Department of Clinical Genetics, Leiden, The Netherlands (FJH, JW).
² Affiliations of authors: Institute of Cancer and Genetics (CGS, HW, RH, SI, JPC) and Institute of Psychological Medicine and Clinical Neurosciences (VM), School of Medicine, Cardiff University, Cardiff, UK; Gray Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK (TSM); MRC Clinical Trials Unit, London, UK (RK); Wellcome Trust Brenner Building, St James' University Hospital, University of Leeds, Leeds, UK (SR, PQ, MS); Institute of Human Genetics, University Hospital Bonn, Bonn, Germany (VS, PP); Leiden University Medical Center, Department of Clinical Genetics, Leiden, The Netherlands (FJH, JW). cheadlejp@cardiff.ac.uk.

No abstract available

Comment on

Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis.
Smith CG, West H, Harris R, Idziaszczyk S, Maughan TS, Kaplan R, Richman S, Quirke P, Seymour M, Moskvina V, Steinke V, Propping P, Hes FJ, Wijnen J, Cheadle JP. Smith CG, et al. J Natl Cancer Inst. 2013 Aug 21;105(16):1249-53. doi: 10.1093/jnci/djt183. Epub 2013 Jul 12. J Natl Cancer Inst. 2013. PMID: 23852950
Re: Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis.
Kinnersley B, Buch S, Castellví-Bel S, Farrington SM, Forsti A, Hampe J, Hemminki K, Hofstra RM, Northwood E, Palles C, Pinheiro M, Ruiz-Ponte C, Schafmayer C, Teixeira MR, Westers H, Wezel Tv, Bishop DT, Tomlinson I, Dunlop MG, Houlston RS. Kinnersley B, et al. J Natl Cancer Inst. 2014 Apr 26;106(5):dju086. doi: 10.1093/jnci/dju086. J Natl Cancer Inst. 2014. PMID: 24771875 Free PMC article. No abstract available.